AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · New Hampshire

HB1693

Relative to the use of psychedelics for therapeutic purposes.

Status

Did not pass; died when the session ended

2024 Session

IntroducedDec 15, 2023 (done)
PassedDid not happen (skipped)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Kevin Verville (Republican)
Type: Therapeutic Access
Substances: Psilocybin

Official text

Summary (from PoliPsy)

Relative to the use of psychedelics for therapeutic purposes.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: gc.nh.gov

Legislative history

October 9, 2024
Executive Session: 10/09/2024 01:00 pm Legislative Office Building 205-207
December 15, 2023
Referred
December 15, 2023
Introduced

Loading bill…